Literature DB >> 31734877

Interictal epileptiform discharges on electroencephalography in children with methylenetetrahydrofolate reductase (MTHFR) polymorphisms.

Elif Karatoprak1, Gulhan Sozen2, Kutluhan Yılmaz3, Işıl Ozer4.   

Abstract

OBJECTIVE: Methylenetetrahydrofolate reductase (MTHFR) is an important enzyme involved in folate metabolism. MTHFR C677T and A1298C polymorphisms are best-defined variants of MTHFR that were reported to be associated with epilepsy development. The aim of the study was to determine the incidence of interictal epileptiform discharges on electroencephalography (EEG) in asymptomatic children with C677T and A1298C polymorphisms who had no history of seizure.
METHODS: Children with MTHFR C677T or A1298C polymorphisms who had normal neurological examination without a history of seizure were included in the study. Blood samples for serum folate, vitamin B12, and homocysteine levels were analyzed. Sleep and awake electroencephalograms (EEG) were recorded.
RESULTS: A total of 102 children (50 girls and 52 boys) with a mean age of 59.4 ± 58.7 months were included in the study. Interictal epileptiform EEG discharges were detected in 3 children (2.9%).
CONCLUSION: There was no increase in the prevalence of interictal epileptiform discharges in seizure-free and asymptomatic children with MTHFR C677T and A1298C polymorphisms.

Entities:  

Keywords:  Children; Electroencephalography; MTHFR; Polymorphism

Year:  2019        PMID: 31734877     DOI: 10.1007/s10072-019-04119-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  28 in total

1.  Total homocysteine in pediatric patients.

Authors:  M A Vilaseca; D Moyano; I Ferrer; R Artuch
Journal:  Clin Chem       Date:  1997-04       Impact factor: 8.327

2.  Association of MTHFR C677T with total homocysteine plasma levels and susceptibility to Parkinson's disease: a meta-analysis.

Authors:  Ying Zhu; Rui-Xia Zhu; Zhi-Yi He; Xu Liu; He-Nan Liu
Journal:  Neurol Sci       Date:  2015-01-07       Impact factor: 3.307

3.  The development of the electroencephalogram in normal children from the age of 1 through 15 years. Paroxysmal activity.

Authors:  O Eeg-Olofsson; I Petersén; U Selldén
Journal:  Neuropadiatrie       Date:  1971-04

Review 4.  Antiepileptic drugs, hyperhomocysteinemia and B-vitamins supplementation in patients with epilepsy.

Authors:  Vincenzo Belcastro; Pasquale Striano
Journal:  Epilepsy Res       Date:  2012-07-21       Impact factor: 3.045

5.  Screening for C677T and A1298C MTHFR polymorphisms in patients with epilepsy and risk of hyperhomocysteinemia.

Authors:  D Caccamo; S Condello; G Gorgone; G Crisafulli; V Belcastro; S Gennaro; P Striano; F Pisani; R Ientile
Journal:  Neuromolecular Med       Date:  2004       Impact factor: 3.843

Review 6.  Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.

Authors:  Mark P Mattson; Thomas B Shea
Journal:  Trends Neurosci       Date:  2003-03       Impact factor: 13.837

Review 7.  Homocysteine and neurologic disease.

Authors:  R Diaz-Arrastia
Journal:  Arch Neurol       Date:  2000-10

8.  Severe and mild mutations in cis for the methylenetetrahydrofolate reductase (MTHFR) gene, and description of five novel mutations in MTHFR.

Authors:  P Goyette; B Christensen; D S Rosenblatt; R Rozen
Journal:  Am J Hum Genet       Date:  1996-12       Impact factor: 11.025

9.  A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase.

Authors:  P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel
Journal:  Nat Genet       Date:  1995-05       Impact factor: 38.330

10.  Mutated methylenetetrahydrofolate reductase as a risk factor for spina bifida.

Authors:  N M van der Put; R P Steegers-Theunissen; P Frosst; F J Trijbels; T K Eskes; L P van den Heuvel; E C Mariman; M den Heyer; R Rozen; H J Blom
Journal:  Lancet       Date:  1995-10-21       Impact factor: 79.321

View more
  1 in total

1.  The Studies of Prognostic Factors and the Genetic Polymorphism of Methylenetetrahydrofolate Reductase C667T in Thymic Epithelial Tumors.

Authors:  Miaolong Yan; Jiayuan Wu; Min Xue; Juanfen Mo; Li Zheng; Jun Zhang; Zhenzhen Gao; Yi Bao
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.